Clinical trials · Michigan
Hidradenitis Suppurativa clinical trials in Michigan
We’re tracking 8 recruiting hidradenitis suppurativa studies with a site in Michigan — including Phase 1, Phase 2 and Phase 3 studies, each written for real people, not researchers.
Recruiting studies in Michigan
- NCT04218422Recruiting
Battlefield-style ear acupuncture for hidradenitis pain
This trial tests a type of ear acupuncture (“battlefield acupuncture”) to reduce pain from hidradenitis suppurativa, a long-term skin condition. You may be eligible if your hidradenitis pain is frequent and your treatments are stable.
Dearborn, MichiganAges 18 years+ - NCT07783542RecruitingPhase 2
Treatment for moderate to severe hidradenitis suppurativa
This study tests a new medication called ORKA-002 to see if it can reduce the number of painful bumps and sores in people with moderate to severe hidradenitis suppurativa (a chronic skin condition). It may be an option for people who have not had success with antibiotic treatments.
Canton, MichiganAges 18–79 - NCT07244263RecruitingPhase 2
Zasocitinib for hidradenitis suppurativa
This trial tests a new daily pill called zasocitinib for people with moderate to severe hidradenitis suppurativa (HS) who haven't been helped enough by antibiotics. It aims to reduce painful lumps and abscesses.
Fort Gratiot, MichiganAges 18 years+ - NCT07213973RecruitingPhase 2
Study of povorcitinib for teens with hidradenitis suppurativa
This trial tests an oral medication called povorcitinib for adolescents aged 12–17 with moderate to severe hidradenitis suppurativa (HS) that hasn't improved with standard treatments like antibiotics. It aims to see how well the drug works and if it's safe.
Auburn Hills, MichiganAges 12–17 - NCT07049575RecruitingPhase 1
Ruxolitinib cream study for hidradenitis suppurativa
This study tests a cream called ruxolitinib for people with hidradenitis suppurativa (HS). The goal is to see how much of the cream is absorbed when it's applied to a large area of the body.
Troy, MichiganAges 12–75 - NCT07007637Enrolling by invitationPhase 3
Long-Term Safety and Effectiveness of Sonelokimab for Hidradenitis Suppurativa
This study offers long-term treatment with an investigational biologic, sonelokimab, for people with moderate to severe hidradenitis suppurativa who finished an earlier sonelokimab study. The goal is to see if sonelokimab remains safe and effective over time.
Ann Arbor, MichiganAges 12 years+ - NCT06524635RecruitingPhase 2
Study of lutikizumab for hidradenitis suppurativa or eczema
This study tests an investigational medicine called lutikizumab, given as shots under the skin, for people with moderate-to-severe hidradenitis suppurativa (HS) or atopic dermatitis (eczema). It looks at how the medicine affects skin changes and may help if other treatments haven’t worked.
Ann Arbor, MichiganAges 18–75 - NCT06855498RecruitingPhase 3
Rollover study for patients who took povorcitinib before
This study is for people who have already taken the study drug povorcitinib in a previous trial and found it helpful. It lets you continue receiving the treatment and allows doctors to keep tracking its long-term safety and effects.
Ann Arbor, MichiganAges 18 years+
Hidradenitis Suppurativa trials by city in Michigan
Where these studies are running in Michigan
Institutions with a site for the recruiting hidradenitis suppurativa studies listed above.
- Revival Research Institute · 2 studies
- Wayne State University · 2 studies
- Clinical Site
- Hamzavi Dermatology
- Investigative Site
- Investigative Site US042
- Investigative Site US061
- Investigative Site US120
What taking part in a hidradenitis suppurativa study involves
A screening visit first
Before anything else, the study team checks whether you fit — usually a visit with some tests. You can stop at any point, and screening is typically free.
Care at a nearby site
Study visits happen at a clinic or hospital taking part. Many studies cover the cost of the study treatment and related visits, and some reimburse travel.
You stay in control
Taking part is voluntary and you can leave a study at any time, for any reason, without affecting your regular care.
The team decides eligibility
Our fit check is a helpful first read, not a decision. The study team makes the final call after reviewing your health history.
Hidradenitis Suppurativa trials in other states
Common questions
- Are there hidradenitis suppurativa clinical trials in Michigan?
- Yes. We're currently tracking 8 recruiting hidradenitis suppurativa studies with a site in Michigan, each rewritten in plain language so you can see what it's testing and who it's for.
- How do I find out if I qualify for a hidradenitis suppurativa study in Michigan?
- Each study lists its eligibility rules — age, diagnosis, prior treatments. On every trial page we explain these in plain language and offer a short, optional pre-screen for a fit read. The study team makes the final decision.
- Do I have to live in Michigan to take part?
- Not necessarily. These studies have a site in Michigan, but eligibility is about your health, not your address — some people travel to take part, and a few studies reimburse travel. The study team can tell you what's required.
- Does it cost anything to join a hidradenitis suppurativa trial?
- Using Clin2 is always free. Many trials cover the study treatment and related visits; some reimburse travel. The study team explains exactly what's covered before you decide.
Not the right time?
New hidradenitis suppurativa studies open in Michigan regularly. Set up a health profile and we’ll quietly watch for studies that fit you and email you when one opens.
Clin2 helps you find and understand clinical trials and does not provide medical advice. Study data comes from ClinicalTrials.gov. Talk with your doctor about whether a specific trial is right for you.